#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis NTRK gene fusion overexpression Infective uveitis Anaemia Lymphangioma Hyperphagia Pelizaeus-Merzbacher disease B-cell small lymphocytic lymphoma Meningitis meningococcal Ataxia telangiectasia Lymphoma Follicular lymphoma Cryoglobulinaemia Langerhans' cell histiocytosis Myelin oligodendrocyte glycoprotein antibody-associated disease More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Treatment Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Congenital generalised lipodystrophy – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease Cerebral arteriovenous malformation haemorrhagic Atypical haemolytic uraemic syndrome – Trials in Disease Haemophilia A with anti factor VIII – Diagnostics Fragile X syndrome – Life with Disease Synovial sarcoma recurrent – Diagnostics KBG syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Belzupacap Sarotalocan Valganciclovir Hydrochloride Sulfamethoxazole Avb-101 Ertapenem Sodium Flutafuranol (18F) NIZUBAGLUSTAT Bleomycin Sulfate Ph. Eur. Ecopipam Hydrochloride Cannabidiol Salbutamol Glutathione FLUCLOXACILLIN SODIUM Iomeprol Sodium Chloride Solution 0.9% CHLOROQUINE PHOSPHATE Tozinameran Cangrelor Tetrasodium Tianeptine Sodium ZIRCONIUM (89ZR) GIRENTUXIMAB More therapies…

    Learn about Your Condition

    Post-traumatic stress disorder Tuberous sclerosis complex Pleomorphic leiomyosarcoma External cephalic version Bile acid synthesis disorder Benign prostatic hyperplasia Procedural pain Fibrous dysplasia of bone Usher's syndrome Cortical dysplasia Pain in extremity Hypochromic anaemia H1N1 influenza Pyelonephritis acute HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colon cancer

  • A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases

    Recruiting

    1 1
    Investigated Diseases:
    • Colon cancer stage III
    • Colon cancer
    France Germany Spain

  • A study evaluating the effects of intravenous lidocaine on pain control and recovery after colon cancer surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    Slovenia

  • Study of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Dostarlimab
    Belgium

  • Study on the Effectiveness of Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine for Patients with Locally Advanced Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    Spain

  • Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Rectal cancer
    Investigated Drugs:
    • Encorafenib
    • Cetuximab
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!